Komori
Governance3750ADR Biomedical Holdings Inc.Electrical Equipment and Precision Instruments

Notice Regarding Partial Amendments to the Articles of Incorporation

Subject to approval at the General Meeting of Shareholders, the corporate name will change from 「株式会社ADR120S」 to 「ADRバイオメディカルホールディングス株式会社」 effective 1 July 2026. The company's business purposes will also be added to and amended to include regenerative medicine, medical devices, medical information and other areas.

Worth reading
—
Scored from 0 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Governance structure

Company with an Audit and Supervisory Committee
Changes this time

The corporate name will be changed, and the business purposes will be added to and amended to include regenerative medicine, medical devices, medical information systems and personal health records (PHR), investment in, business development for and management support of healthcare-related businesses, and intellectual property-related businesses. The effective date of the corporate name change is scheduled for 1 July 2026.

Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit and Supervisory Committee
Changes this timeThe corporate name will be changed, and the business purposes will be added to and amended to include regenerative medicine, medical devices, medical information systems and personal health records (PHR), investment in, business development for and management support of healthcare-related businesses, and intellectual property-related businesses. The effective date of the corporate name change is scheduled for 1 July 2026.
Items this document does not state (6)
Number of directorsNumber of independent officersCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The corporate name is being changed in connection with the reorganization of the Group structure, and the business purposes are being amended in light of the company's future business development.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Partial Amendments to the Articles of Incorporation | ADR Biomedical Holdings Inc. (3750) timely disclosure | Komori